Stacey DaCosta Byfield

SB-505124 Is a Selective Inhibitor of Transforming Growth Factor-β Type I Receptors ALK4, ALK5, and ALK7

Stacey DaCosta Byfield, Christopher Major, Nicholas J. Laping et al. · Molecular Pharmacology · 2004 · 416 citations

Life Sciences, Medicinal Chemistry, Pharmacology +13

Underutilization of BRCA1/2 testing to guide breast cancer treatment: Black and Hispanic women particularly at risk

Douglas E. Levy, Stacey DaCosta Byfield, Catherine Comstock et al. · Genetics in Medicine · 2011 · 242 citations · Full text

Medicine, Oncology, Breast Oncology +8

Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-α and TGF-β

Christina H. Stuelten, Stacey DaCosta Byfield, Praveen Arany et al. · Journal of Cell Science · 2005 · 237 citations · Full text

Medicine, Cell Biology, Oncology +17

Reduction in Smad2/3 signaling enhances tumorigenesis but suppresses metastasis of breast cancer cell lines.

Fang Tian, Stacey DaCosta Byfield, W. Tony Parks et al. · PubMed · 2003 · 178 citations

Medicine, Cancer Biology, Oncology +17

Loss of Smad3 in Acute T-Cell Lymphoblastic Leukemia

Lawrence A. Wolfraim, Tania Miñes Fernández, Mizuko Mamura et al. · New England Journal of Medicine · 2004 · 165 citations · Full text

Life Sciences, Molecular Biology, Oncology +17